ACIFORMULA Aci Formulations Limited
Pharmaceuticals & Chemicals
Tk 139 as of 2026-11-12 14:00:00
Rank 68 of all scored
Data completeness 100%
Data completeness 100%
Score breakdown
Consistency 92
Profitability 59
Solvency 67
Valuation 49
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency EPS grew in 3 of 4 years
- Consistency Paid a dividend every year (5/5)
- Profitability Net profit growing 14.82% a year
- Ownership Institutions (20.15%) hold more than the public (13.83%)
Concerns
- Profitability Average ROE only 9.14% (below 10%: capital not working hard)
Notes
- Solvency Debt/equity 0.95x (well managed)
- Valuation P/E 17.46 is fair
Risk flags
- Mid cap (Tk 200-1,000 cr)
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
20.9% above the low, 26.5% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 66%
- Institution 20.2%
- Public 13.8%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 4.74 | 66.77 | 21 | 30 | 5 |
| 2022 | 5.14 | 65.88 | 24 | 25 | 0 |
| 2023 | 4.97 | 64.57 | 23 | 25 | 0 |
| 2024 | 6.88 | 68.94 | 32 | 20 | 0 |
| 2025 | 7.85 | 75.51 | 37 | 25 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 55.5%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.